EAM
EULAV Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.1M | Sell |
22,700
-5,800
| -20% | -$2.58M | 0.24% | 98 |
|
2025
Q1 | $13.8M | Hold |
28,500
| – | – | 0.34% | 77 |
|
2024
Q4 | $11.5M | Sell |
28,500
-3,000
| -10% | -$1.21M | 0.28% | 90 |
|
2024
Q3 | $14.7M | Sell |
31,500
-4,500
| -13% | -$2.09M | 0.36% | 77 |
|
2024
Q2 | $16.9M | Sell |
36,000
-1,900
| -5% | -$891K | 0.46% | 62 |
|
2024
Q1 | $15.8M | Sell |
37,900
-500
| -1% | -$209K | 0.44% | 64 |
|
2023
Q4 | $15.6M | Buy |
38,400
+5,000
| +15% | +$2.03M | 0.48% | 59 |
|
2023
Q3 | $11.6M | Sell |
33,400
-2,100
| -6% | -$730K | 0.42% | 71 |
|
2023
Q2 | $12.5M | Sell |
35,500
-2,000
| -5% | -$704K | 0.47% | 62 |
|
2023
Q1 | $11.8M | Sell |
37,500
-4,500
| -11% | -$1.42M | 0.47% | 62 |
|
2022
Q4 | $12.1M | Sell |
42,000
-6,010
| -13% | -$1.74M | 0.52% | 58 |
|
2022
Q3 | $13.9M | Sell |
48,010
-5,998
| -11% | -$1.74M | 0.62% | 57 |
|
2022
Q2 | $15.2M | Sell |
54,008
-5,999
| -10% | -$1.69M | 0.63% | 56 |
|
2022
Q1 | $15.7M | Sell |
60,007
-19,993
| -25% | -$5.22M | 0.47% | 66 |
|
2021
Q4 | $17.6M | Sell |
80,000
-28,000
| -26% | -$6.15M | 0.44% | 73 |
|
2021
Q3 | $19.6M | Sell |
108,000
-34,000
| -24% | -$6.17M | 0.52% | 67 |
|
2021
Q2 | $28.6M | Sell |
142,000
-8,000
| -5% | -$1.61M | 0.76% | 45 |
|
2021
Q1 | $32.2M | Buy |
150,000
+72,000
| +92% | +$15.5M | 0.86% | 38 |
|
2020
Q4 | $18.4M | Buy |
78,000
+31,500
| +68% | +$7.44M | 0.48% | 76 |
|
2020
Q3 | $12.7M | Sell |
46,500
-20
| -0% | -$5.44K | 0.37% | 91 |
|
2020
Q2 | $13.5M | Sell |
46,520
-4,480
| -9% | -$1.3M | 0.44% | 77 |
|
2020
Q1 | $12.1M | Sell |
51,000
-7,000
| -12% | -$1.67M | 0.49% | 71 |
|
2019
Q4 | $12.7M | Sell |
58,000
-11,000
| -16% | -$2.41M | 0.44% | 78 |
|
2019
Q3 | $11.7M | Sell |
69,000
-3,000
| -4% | -$508K | 0.43% | 77 |
|
2019
Q2 | $13.2M | Hold |
72,000
| – | – | 0.5% | 65 |
|
2019
Q1 | $13.4M | Sell |
72,000
-7,000
| -9% | -$1.3M | 0.55% | 60 |
|
2018
Q4 | $13.1M | Sell |
79,000
-16,000
| -17% | -$2.65M | 0.65% | 51 |
|
2018
Q3 | $18.3M | Sell |
95,000
-12,000
| -11% | -$2.31M | 0.78% | 36 |
|
2018
Q2 | $18.2M | Sell |
107,000
-10,000
| -9% | -$1.7M | 0.84% | 33 |
|
2018
Q1 | $19.1M | Sell |
117,000
-16,000
| -12% | -$2.61M | 0.91% | 27 |
|
2017
Q4 | $19.9M | Buy |
133,000
+8,000
| +6% | +$1.2M | 0.94% | 24 |
|
2017
Q3 | $19M | Sell |
125,000
-4,000
| -3% | -$608K | 0.9% | 28 |
|
2017
Q2 | $16.6M | Sell |
129,000
-8,000
| -6% | -$1.03M | 0.81% | 32 |
|
2017
Q1 | $15M | Sell |
137,000
-5,000
| -4% | -$547K | 0.76% | 37 |
|
2016
Q4 | $10.5M | Sell |
142,000
-6,000
| -4% | -$442K | 0.56% | 60 |
|
2016
Q3 | $12.9M | Buy |
148,000
+12,000
| +9% | +$1.05M | 0.68% | 44 |
|
2016
Q2 | $11.7M | Sell |
136,000
-10,000
| -7% | -$860K | 0.64% | 51 |
|
2016
Q1 | $11.6M | Buy |
146,000
+25,000
| +21% | +$1.99M | 0.65% | 53 |
|
2015
Q4 | $15.2M | Sell |
121,000
-1,000
| -0.8% | -$126K | 0.83% | 32 |
|
2015
Q3 | $12.7M | Buy |
122,000
+96,000
| +369% | +$10M | 0.72% | 40 |
|
2015
Q2 | $3.21M | Buy |
+26,000
| New | +$3.21M | 0.17% | 180 |
|